2013 American Transplant Congress
T Cell Help Is Critical in Determining Mode of Alloantibody-Mediated Allograft Rejection
Department of Surgery, University of Cambridge, Cambridge, United Kingdom
INTRODUCTION. What determines whether alloantibody mediates acute or chronic allograft rejection remains unclear; here we examine the role of CD4 T cell help.METHODS. BALB/c hearts…2013 American Transplant Congress
Clinical and Mechanistic Study of How Innate Immunity Gene Polymorphisms Can Affect Influenza Vaccine Responses Post-Transplant, A
University of Alberta, Edmonton, Canada
Background: Interferons modulate the innate and adaptive immune response to viruses and vaccines. Transplant recipients respond poorly to influenza vaccine. The contribution of IFNΛ and…2013 American Transplant Congress
Comparison of 20-Year Patient and Graft Survival for All Types of Solid Organ Transplants (Txs)
Purpose: To compare long-term patient survival and graft function (≥ 20 years) for all types of solid organ transplants (SOTs) and to define the state-of-the-art…2013 American Transplant Congress
Salt Intake and Post-Transplant Hypertension in Kidney Transplant Recipients
Nephrology, Hospital Marqués de Valdecilla, Santander, Spain
Up to 90% of kidney transplant recipients (KTx) develop hypertension. Both systolic and diastolic post-transplant hypertension relate to patient and allograft survival. In the general…2013 American Transplant Congress
Outcomes of Latent Tuberculosis Screening and Therapy in Transplant Recipients over a 10 Year Period
Univ of Alberta, Edmonton, Canada
INTRODUCTION: Pre-transplant screening and therapy of latent tuberculosis infection (LTBI) is recommended. However, there are limited data on the tolerability of LTBI therapy pre- and…2013 American Transplant Congress
Liver Transplantation from Donors with past History of Malignancies: A Single Center Experience
Dept. of General- and Transplantation Surgery, University Clinic, Essen, Germany
Introduction: The demand for transplantable organs exceeds donor supply. Transplantation of organs from donors with past history of malignancy is controversial, and the transmission of…2013 American Transplant Congress
CKD-EPI (Cr+Cystatin C) Is a Vastly More Precise Formula in Kidney Transplant Recipients, The
University of Minnesota, Minneapolis
GFR estimates incorporating cystatin C (CysC) and creatinine (Cr) have shown to perform better than Cr only in subjects with reduced GFR but have not…2013 American Transplant Congress
Urinary Protein Excretion in Non-Renal Transplant Patients – Does mTOR-Inhibitor Treatment Matter?
The H2304 Study Group, Basel, Switzerland
BackgroundThe interplay of glomerular filtration and tubular absorption of proteins with various molecular weights defines the pattern and magnitude of daily urinary protein excretion (UPE).…2013 American Transplant Congress
Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART
Recent data raised question regarding the safety of everolimus (EVR) in the early post-operative period in de novo heart transplant (HT) recipients. Thus, we have…2013 American Transplant Congress
7 Years Experience with Multiplex TMA-NAT-Based Assay for HIV and HCV Screening among Organ and Tissue Donors – Definitive Report
BACKGROUND Transplant professionals must be able to rely on organ and tissue screening tests to accurately detect the presence of viruses and their antibodies. Antiviral…
- « Previous Page
- 1
- …
- 67
- 68
- 69
- 70
- 71
- …
- 178
- Next Page »